ヘルスとヘルスケア
New malaria vaccine: The key questions answered
The world’s first mass vaccination program against malaria, announced this week, is set to prevent millions of children from catching malaria and thousands dying from this debilitating di...
Professor Good is Principal Research Leader & NHMRC Australia Fellow, Institute for Glycomics.
Research Interests:
Immunity and immunopathogenesis to malaria and group A streptococcus/rheumatic fever, with particular relevance to the development of vaccines.